Advisory Services Network’s Briacell Therapeutics BCTX Stock Holding History

Advisory Services Network’s Portfolio BCTX Stock Details BCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2	Closed	-$1.75K	–	1669
2023 Q4	$1.75K	Buy	+2	New	+$1.44K	﹤0.01%	3426
2023 Q2	–	Sell	-4	Closed	-$4.84K	–	1655
2023 Q1	$4.84K	Sell	4 -4	-50%	-$4.15K	﹤0.01%	3163
2022 Q4	$5.14K	Buy	+8	New	+$6.78K	﹤0.01%	3114
2021 Q3	–	Sell	-30	Closed	-$24K	–	1563
2021 Q2	$24K	Buy	+30	New	+$18.7K	﹤0.01%	2410

Other funds holding BCTX

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

RAM

Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return

KJHP

K.J. Harrison & Partners Toronto, Ontario, Canada $608M AUM 45.31% 1-Year Est. Return

OBWG

Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return

STA

Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Advisory Services Network's BCTX Position: Q1 2024 in Review

Advisory Services Network sold out of Briacell Therapeutics (BCTX) in Q1 2024, closing a stake of 2 shares — an estimated $1.75K sold.

Advisory Services Network first reported a position in BCTX in Q2 2021 and held it in 4 quarters. The position peaked at $24K in Q2 2021. 19 funds tracked by Wall St. Rank hold BCTX as of Q1 2024.

Advisory Services Network reported no remaining Briacell Therapeutics position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 2 Briacell Therapeutics shares in Q1 2024, an estimated $1.75K.
Advisory Services Network first reported a position in Briacell Therapeutics in Q2 2021 and held it in 4 quarters.
Advisory Services Network's Briacell Therapeutics position peaked at $24K in Q2 2021.
19 funds tracked by Wall St. Rank held Briacell Therapeutics as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.